Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Precision Spine wins FDA 510(k) for AccuFit lateral plate system
Precision Spine said today it won FDA 510(k) clearance for its AccuFit lateral plating system designed to treat spinal instability.
The Parsippany, N.J.-based company’s AccuFit lateral plate system consists of non-sterile, single use rigid plates designed to attach to the lateral portions of the vertebral body of the thoracolumbar spine with bone screws. Read more
4. MiMedx enters legal spat with 2 former sales reps
MiMedx this month released information on lawsuits filed against and by the company involving 2 former sales reps.
The Marietta, Ga.-based company said it terminated the employees after finding that they had sold other company’s products “in violation of their contractual and common law duties to MiMedx.” Read more
3. Endologix puts hold on AFX shipments over manufacturing issues
Endologix said today it is temporarily holding shipments of its AFX Endovascular abdominal aortic aneurysm system as it completes an investigation of manufacturing issues with the devices.
The AFX system is designed to provide anatomical fixation to treat a wide range of AAA anatomies, according to the company. Read more
2. Neovasc granted stay as it appeals $70m CardiAQ loss
Neovasc said today it won a stay of judgement as it looks to appeal a $70 million loss to mitral valve rival and Edwards Lifesciences subsidiary CardiAQ Valve.
The stay from the US District Court for the District of Massachusetts restricts CardiAQ from enforcing the money judgement “pending the outcome of the appeal,” the company said. Read more
1. Abbott wins US antitrust approval for $25B St. Jude buy
The US Federal Trade Commission today granted approval to Abbott to complete its proposed $25 billion acquisition of St. Jude Medical.
The approval came with a caveat that the companies divest themselves of 2 cardiovascular medical device businesses – vascular closure devices and “steerable” sheaths. Read more